Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
270 participants
OBSERVATIONAL
2015-08-31
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
At the beginning of December 2015, 70 participants were included in the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Economic Evaluation of Periodic Occupational Health Screening
NCT04684316
Exposure, Dose, Body Burden and Health Effects of Lead
NCT00013819
Health Literacy in the General Population in Belgium
NCT03561636
SEEK Study - Study on Emergency Health Care Workers' Job Strain Evaluated by Karasek Questionnaire
NCT02401607
Burn Out Among Medical Family Doctors
NCT04242862
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Whether low-level lead exposure impacts on blood pressure, regulation of the cardiovascular system, glomerular or tubular renal function, sympathetic nervous modulation, peripheral nervous conduction velocity, and neurocognitive function remains uncertain.
Study Population
* SPHERL will enroll 500 lead recycling workers with changing lead exposure, who will be examined at baseline (2014-2015) and followed up at annual intervals for 2 years (2016-2017).
Methods
* Volunteers eligible for the study are (i) new and existing hires without previous occupational lead exposure who will be performing tasks with or without occupational lead exposure and (ii) existing hires with occupational lead exposure who will be transitioning to job tasks without occupational lead exposure within the next 2 years.
* Blood lead concentration will be the main biomarker of exposure.
* The main outcome variables are (i) blood pressure measured conventionally and by ambulatory monitoring, and analyzed as continuous or categorical variable, both cross-sectionally and longitudinally; (ii) indexes of glomerular and tubular renal function, (iii) heart rate variability analyzed in the frequency domain as measure of autonomous sympathetic modulation, (iv) peripheral nerve conductivity, (v) neurocognitive performance, (vi) and quality of life \[the EuroQOL five dimensions (EQ-5D) questionnaire\].
Expected Outcomes
* Assuming a 4-fold or higher surge in the blood lead concentration, the study is powered to demonstrate over 2 years an acceleration in the age-related rise of systolic blood pressure by 1 to 4 mm Hg or an increase of the coefficient of multiple determination (R2) from 0.22 to 0.24 by adding the change in the blood lead concentration to models relating changes in blood pressure to three other covariables. The longitudinal design of our study complies with the temporality principle of the Bradford-Hill criteria for assessing possible causality between outcomes and exposure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lead exposure
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* New hires without previous occupational lead exposure who will be performing tasks with lead exposure or current employees without previous occupational lead exposure moving to tasks with exposure.
* Informed written consent.
Exclusion Criteria
* Any serious health condition.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jan A. Staessen
Professor of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jan A Staessen, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Leuven
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Leuven
Leuven, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hara A, Gu YM, Petit T, Liu YP, Jacobs L, Zhang ZY, Yang WY, Jin Y, Thijs L, Wei FF, Nawrot TS, Staessen JA. Study for Promotion of Health in Recycling Lead - Rationale and design. Blood Press. 2015 Jun;24(3):147-57. doi: 10.3109/08037051.2014.996409. Epub 2015 Jan 26.
Yu YL, An DW, Yang WY, Verhamme P, Allegaert K, Nawrot TS, Staessen JA. Blood pressure and renal function responses in workers exposed to lead for up to six years. J Clin Hypertens (Greenwich). 2023 Dec;25(12):1086-1095. doi: 10.1111/jch.14748. Epub 2023 Nov 8.
Yu YL, Thijs L, Saenen N, Melgarejo JD, Wei DM, Yang WY, Yu CG, Roels HA, Nawrot TS, Maestre GE, Staessen JA, Zhang ZY. Two-year neurocognitive responses to first occupational lead exposure. Scand J Work Environ Health. 2021 Apr 1;47(3):233-243. doi: 10.5271/sjweh.3940. Epub 2020 Dec 4.
Yu YL, Yang WY, Thijs L, Melgarejo JD, Yu CG, Wei DM, Wei FF, Nawrot TS, Zhang ZY, Staessen JA. Two-Year Responses of Office and Ambulatory Blood Pressure to First Occupational Lead Exposure. Hypertension. 2020 Oct;76(4):1299-1307. doi: 10.1161/HYPERTENSIONAHA.120.15590. Epub 2020 Sep 9.
Yu CG, Wei FF, Yang WY, Zhang ZY, Mujaj B, Thijs L, Feng YM, Staessen JA. Heart rate variability and peripheral nerve conduction velocity in relation to blood lead in newly hired lead workers. Occup Environ Med. 2019 Jun;76(6):382-388. doi: 10.1136/oemed-2018-105379. Epub 2019 Mar 30.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SPHERL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.